Exploring the capability of mayenite (12CaO·7Al₂O₃) as hydrogen storage material

We utilized nanoporous mayenite (12CaO·7Al₂O₃), a cost-effective material, in the hydride state (H⁻) to explore the possibility of its use for hydrogen storage and transportation. Hydrogen desorption occurs by a simple reaction of mayenite with water, and the nanocage structure transforms into a calcium aluminate hydrate. This reaction enables easy desorption of H⁻ ions trapped in the structure, which could allow the use of this material in future portable applications. Additionally, this material is 100% recyclable because the cage structure can be recovered by heat treatment after hydrogen desorption. The presence of hydrogen molecules as H⁻ ions was confirmed by ¹H-NMR, gas chromatography, and neutron diffraction analyses. We confirmed the hydrogen state stability inside the mayenite cage by the first-principles calculations to understand the adsorption mechanism and storage capacity and to provide a key for the use of mayenite as a portable hydrogen storage material. Further, we succeeded in introducing H⁻ directly from OH⁻ by a simple process compared with previous studies that used long treatment durations and required careful control of humidity and oxygen gas to form O₂ species before the introduction of H⁻

Hot debris dust around HD 106797

Photometry of the A0 V main-sequence star HD 106797 with AKARI and Gemini/T-ReCS is used to detect excess emission over the expected stellar photospheric emission between 10 and 20 micron, which is best attributed to hot circumstellar debris dust surrounding the star. The temperature of the debris dust is derived as Td ~ 190 K by assuming that the excess emission is approximated by a single temperature blackbody. The derived temperature suggests that the inner radius of the debris disk is ~ 14 AU. The fractional luminosity of the debris disk is 1000 times brighter than that of our own zodiacal cloud. The existence of such a large amount of hot dust around HD 106797 cannot be accounted for by a simple model of the steady state evolution of a debris disk due to collisions, and it is likely that transient events play a significant role. Our data also show a narrow spectral feature between 11 and 12 micron attributable to crystalline silicates, suggesting that dust heating has occurred during the formation and evolution of the debris disk of HD 106797.Comment: Accepted to ApJ Letters, 8 pages, 2 figure

Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-

The purpose of this study was to evaluate the retention and discontinuation reasons of seven biological disease-modifying antirheumatic drugs (bDMARDs) in a real-world setting of patients with rheumatoid arthritis (RA). 1,037 treatment courses with bDMARDs from 2009 to 2016 [female, 81.8%; baseline age, 59.6 y; disease duration 7.8 y; rheumatoid factor positivity 81.5%; Disease Activity Score in 28 joints using erythrocyte sedimentation rate (DAS28-ESR), 4.4; concomitant prednisolone 43.5% and methotrexate 68.6%; Bio-naïve, 57.1%; abatacept (ABT), 21.3%; tocilizumab (TCZ), 20.7%; golimumab (GLM), 16.9%; etanercept (ETN), 13.6%; adalimumab (ADA), 11.1%; infliximab (IFX), 8.5%; certolizumab pegol (CZP), 7.9%] were included in this multi-center, retrospective study. Drug retention and discontinuation reasons at 36 months were estimated using the Kaplan-Meier method and adjusted by potent confounders using Cox proportional hazards modeling. As a result, 455 treatment courses (43.9%) were stopped, with 217 (20.9%) stopping due to inefficacy, 113 (10.9%) due to non-toxic reasons, 86 (8.3%) due to toxic adverse events, and 39 (3.8%) due to remission. Drug retention rates in the adjusted model were as follows: total retention (ABT, 60.7%; ADA, 32.7%; CZP, 43.3%; ETN, 51.9%; GLM, 45.4%; IFX, 31.1%; and TCZ, 59.2%; P < 0.001); inefficacy (ABT, 81.4%; ADA, 65.7%; CZP, 60.7%; ETN, 71.3%; GLM, 68.5%; IFX, 65.0%; and TCZ, 81.4%; P = 0.015), toxic adverse events (ABT, 89.8%; ADA, 80.5%; CZP, 83.9%; ETN, 89.2%; GLM, 85.5%; IFX, 75.6%; and TCZ, 77.2%; P = 0.50), and remission (ABT, 95.5%; ADA, 88.1%; CZP, 91.1%; ETN, 97.5%; GLM, 94.7%; IFX, 86.4%; and TCZ, 98.4%; P < 0.001). In the treatment of RA, ABT and TCZ showed higher overall retention, and TCZ showed lower inefficacy compared to IFX, while IFX showed higher discontinuation due to remission compared to ABT, ETN, GLM, and TCZ in adjusted modeling.Ebina K., Hashimoto M., Yamamoto W., et al. (2018) Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-. PLoS ONE 13(3): e0194130. doi: 10.1371/journal.pone.0194130

The Far-Infrared Surveyor (FIS) for AKARI

The Far-Infrared Surveyor (FIS) is one of two focal plane instruments on the AKARI satellite. FIS has four photometric bands at 65, 90, 140, and 160 um, and uses two kinds of array detectors. The FIS arrays and optics are designed to sweep the sky with high spatial resolution and redundancy. The actual scan width is more than eight arcmin, and the pixel pitch is matches the diffraction limit of the telescope. Derived point spread functions (PSFs) from observations of asteroids are similar to the optical model. Significant excesses, however, are clearly seen around tails of the PSFs, whose contributions are about 30% of the total power. All FIS functions are operating well in orbit, and its performance meets the laboratory characterizations, except for the two longer wavelength bands, which are not performing as well as characterized. Furthermore, the FIS has a spectroscopic capability using a Fourier transform spectrometer (FTS). Because the FTS takes advantage of the optics and detectors of the photometer, it can simultaneously make a spectral map. This paper summarizes the in-flight technical and operational performance of the FIS.Comment: 23 pages, 10 figures, and 2 tables. Accepted for publication in the AKARI special issue of the Publications of the Astronomical Society of Japa

Image Sensor Communication for Patient ID Recognition Using Mobile Devices

Our research group has developed electronic triage tags for measuring vital signs of patients at critical accidents or disaster sites. Although they have wireless networking facilities to transmit the data to a remote server, it is helpful for doctors at the sites to display the vital signs on their visions by augmented reality. For this purpose, we need recognize identification numbers (IDs) of those tags in doctor’s vision to obtain the vital signs of the patients from the remote server. In this paper, we propose image sensor communication for ID recognition using embedded cameras in commercial off-the-shelf mobile devices. An LED is attached to a patient and controlled to send the patient ID by blinking patterns. In order for avoiding bit losses and errors due to jitter and capture delays, we derive a necessary and sufficient condition for image capturing intervals. Moreover, we have designed an image sensor communication system using Manchester code for robustness in terms of clock drift. Through experiments using a prototype, we have confirmed the proposed system can recognize more than 94 % of 8 bit IDs in 4.5 seconds on average

Melting relations in the Fe–S–Si system at high pressure and temperature: implications for the planetary core

Abstract The phase and melting relations in the Fe–S–Si system were determined up to 60 GPa by using a double-sided laser-heated diamond anvil cell combined with X-ray diffraction. On the basis of the X-ray diffraction patterns, we confirmed that hcp/fcc Fe–Si alloys and Fe3S are stable phases under subsolidus conditions in the Fe–S–Si system. Both solidus and liquidus temperatures are significantly lower than the melting temperature of pure Fe and both increase with pressure. The slopes of the Fe–S–Si liquidus and solidus curves determined here are smaller than the adiabatic temperature gradients of the liquid cores of Mercury and Mars. Thus, crystallization of their cores started at the core–mantle boundary region

RENOVASCULAR HYPERTENSION AND ERECTILE DYSFUNCTION SECONDARY TO POLYARTERITIS NODOSA : A CASE REPORT

We describe a patient with secondary hypertension and erectile dysfunction due to polyarteritis nodosa. A 30-year-old man was admitted because of hypertension and impotence. Blood pressure was 156/94 mm Hg, and was similar in both arms. Superficial sensation was diminished in the soles of the feet. Plasma renin activity was elevated. Intra-arterial digital subtraction angiography (DSA) of the renal arteries showed bilateral multiple microaneurysms in peripheral arterial branches between the interlobular and arcuate arteries of both kidneys. DSA of the internal iliac artery, the internal pudendal artery, and the hepatic artery also showed multiple microaneurysms, as well as focal stenoses. A diagnosis of organic (vascular) erectile dysfunction was made based on findings by the Rigi-scan (Dacomed Inc.). The patient, then, had polyarteritis nodosa presenting hypertension and erectile dysfunction

Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.

BACKGROUND:We aimed to identify associations between erythroferrone (ERFE), a regulator of hepcidin 25, and biomarkers of erythropoiesis and iron metabolism. We also aimed to determine the effects of erythropoiesis-stimulating agents (ESA), continuous erythropoietin receptor activator (CERA) and darbepoetin-α (DA) on ERFE production in patients on hemodialysis (HD). METHODS:Blood samples were obtained from 59 patients before HD sessions on day 0 (baseline). Twenty patients who were injected with either CERA (N = 10) or DA (N = 10) at the end of the dialysis week (day 0), who had ferritin ≥ 100 ng/mL and/or transferrin saturation ≥ 20%, and hemoglobin > 9 g/dL were selected from among the 59 patients. Blood was sampled serially before HD sessions on days 3, 5, 7 from patients on DA and on the same days plus day 14 from those on CERA. RESULTS:Levels of ERFE correlated inversely with those of hepcidin 25 and ferritin, and positively with those of soluble transferrin receptor. The hepcidin 25: ERFE ratio and hepcidin 25 levels positively correlated with ferritin levels. Levels of ERFE significantly increased from day 3 of treatment with DA and CERA and decreased by days 7 and 14, respectively. Erythropoiesis-stimulating agents concomitantly decreased levels of hepcidin 25 as those of ERFE increased. CONCLUSION:We identified a novel association between ESA and ERFE in patients on HD. Both DA and CERA increased levels of ERFE that regulated hepcidin 25 and led to iron mobilization from body stores during erythropoiesis

A CASE OF MALIGNANT RENAL NEOPLASM WITH RHABDOID FEATURES IN AN ADULT

We report a case of malignant neoplasm with rhabdoid features of the kidney in a 68 year old man. To our knowledge malignant rhabdoid tumor of the kidney (MRTK) has been limited to the pediatric age group. Malignant renal neoplasm similar to MRTK occurring in adults is very rare. However, there has been a recent review in which the authors found 23/480 cases of renal cell carcinoma (RCC) (4.7%) exhibiting rhabdoid features, all in adults. In the present case, examination of many sections of tumor-affected tissue revealed no sign of any other malignant tumor included RCC, so-called pure adult malignant rhabdoid tumor in the kidney. MRTK does not respond well to aggressive chemotherapy regimens and survival tends to be short. This patient remains alive with no metastasis and local recurrence more than 45 months from the operation without adjuvant therapy